Trial intelligence / Profile preview

Timing of Midazolam for PONV in Laparoscopic Gynecological Surgery

NCT05057767Completed

Sponsor
Benha University
Start
Sep 2021
Primary completion
Jun 2022
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of midazolam in postoperative nausea and vomiting (PONV) (3 arms), sponsored by Benha University. Primary endpoint: Post Operative Nausea Vomiting assessment at 24 hours. Started Sep 2021; status: completed.

02

Drugs

midazolam
03

Conditions

postoperative nausea and vomiting (PONV)

Beyond the preview

Go deeper on NCT05057767.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05057767.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call